Bruker Corp (NASDAQ:BRKR) Institutional Investors Sentiment Index Flat in Q2 2018

Bruker Corporation (NASDAQ:BRKR) Logo

Sentiment for Bruker Corp (NASDAQ:BRKR)

Bruker Corp (NASDAQ:BRKR) institutional sentiment is 1.04 in Q2 2018. Its the same as in 2018Q1. The ratio is without change, as only 96 funds increased or started new positions, while 92 sold and reduced their equity positions in Bruker Corp. The funds in our partner’s database now own: 99.72 million shares, up from 99.02 million shares in 2018Q1. Also, the number of funds holding Bruker Corp in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 22 Reduced: 70 Increased: 65 New Position: 31.

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions worldwide. The company has market cap of $4.98 billion. The firm operates through two divisions, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It has a 50.64 P/E ratio. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear and explosive detection in emergency response, homeland security, and defense applications; and analytical and process analysis instruments and solutions.

The stock decreased 3.46% or $1.14 during the last trading session, reaching $31.8. About 671,818 shares traded or 6.07% up from the average. Bruker Corporation (NASDAQ:BRKR) has risen 17.30% since December 6, 2017 and is uptrending. It has outperformed by 1.68% the S&P500.

Analysts await Bruker Corporation (NASDAQ:BRKR) to report earnings on February, 14. They expect $0.54 earnings per share, up 5.88 % or $0.03 from last year’s $0.51 per share. BRKR’s profit will be $84.52 million for 14.72 P/E if the $0.54 EPS becomes a reality. After $0.37 actual earnings per share reported by Bruker Corporation for the previous quarter, Wall Street now forecasts 45.95 % EPS growth.

Thompson Rubinstein Investment Management Inc Or holds 1.37% of its portfolio in Bruker Corporation for 141,412 shares. Palisade Capital Management Llc Nj owns 737,540 shares or 0.62% of their US portfolio. Moreover, Acadian Asset Management Llc has 0.59% invested in the company for 4.71 million shares. The California-based First Quadrant L P Ca has invested 0.45% in the stock. Zebra Capital Management Llc, a Connecticut-based fund reported 34,736 shares.

More notable recent Bruker Corporation (NASDAQ:BRKR) news were published by: Stockhouse.com which released: “Bruker Announces Quarterly Dividend – Stockhouse” on November 09, 2018, also Seekingalpha.com with their article: “Premarket analyst action – healthcare – Seeking Alpha” published on September 20, 2018, Nasdaq.com published: “Bruker Unveils New Mass-Spectrometry Products, Boosts CALID – Nasdaq” on June 04, 2018. More interesting news about Bruker Corporation (NASDAQ:BRKR) were released by: Prnewswire.com and their article: “Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH – PR Newswire” published on October 16, 2018 as well as Schaeffersresearch.com‘s news article titled: “Corbus Leads Nasdaq on Drug Licensing Deal – Schaeffers Research” with publication date: September 20, 2018.

Bruker Corporation (NASDAQ:BRKR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.